Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1

被引:66
|
作者
Lautraite, S
Musonda, AC
Doehmer, J
Edwards, GO
Chipman, JK [1 ]
机构
[1] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
[2] GenPharmTox Biotech AG, D-82152 Martinsried, Germany
关键词
D O I
10.1093/mutage/17.1.45
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The effects of the flavonoids quercetin, apigenin and chrysin (10 muM) on the genetic toxicity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and benzo[a]pyrene (BaP) was investigated at sub-cytotoxic concentrations in Chinese hamster V79 cells expressing human or rat cytochromes P450. In V79 r1A2-NH and V79 h1A1-MZ cells, none of the flavonoids increased DNA strand breaks (SB) (measured by the Comet assay) or produced detectable DNA adducts (measured by P-32-post-labelling). Neither IQ nor BaP produced DNA damage in the absence of expressed CYP1A2 or CYP1A1, respectively. DNA damage measured as SB and DNA adducts was detectable in V79 r1A2-NH cells expressing rat CYP1A2 when treated with IQ (2.5-50 muM) and this was inhibited by quercetin. Likewise, DNA damage (SB and DNA adducts) was elevated in V79 h1A1-MZ cells expressing human CYP1A1 when treated with BaP (0.1-0.5 muM) and this was inhibited by chrysin and apigenin, but not by quercetin. The specificity of CYP1A1 inhibition by chrysin and apigenin and CYP1A2 inhibition by quercetin was confirmed by ethylresorufin O-deethylase assay.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 50 条
  • [1] Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice
    Kapelyukh, Y.
    Henderson, C. J.
    Scheer, N.
    Rode, A.
    Wolf, C. R.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (08) : 907 - 918
  • [2] CYP1A1/CYP1A2 polymorphisms and colorectal cancer
    Ozhan, Gul
    Mutur, Mine
    TOXICOLOGY LETTERS, 2012, 211 : S69 - S69
  • [3] The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population
    Merve, Arici
    Gul, Ozhan
    SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (02) : 294 - 297
  • [4] Sulforaphane and Its Analogues Inhibit CYP1A1 and CYP1A2 Activity Induced by Benzo[a]pyrene
    Skupinska, Katarzyna
    Misiewicz-Krzeminska, Irena
    Stypulkowski, Rafal
    Lubelska, Katarzyna
    Kasprzycka-Guttman, Teresa
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2009, 23 (01) : 18 - 28
  • [5] CYP1A2 is expressed along with CYP1A1 in the human lung
    Wei, C
    Cacavale, RJ
    Kehoe, JJ
    Thomas, PE
    Iba, MM
    CANCER LETTERS, 2001, 164 (01) : 25 - 32
  • [6] Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9
    Otake, Y
    Walle, T
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (02) : 103 - 105
  • [7] CYP1A1 but not CYP1A2 proteins are expressed in human lymphocytes
    Spatzenegger, M
    Horsmans, Y
    Verbeeck, RK
    PHARMACOLOGY & TOXICOLOGY, 2000, 86 (05): : 242 - 244
  • [8] EXPRESSION OF CYP1A1 AND CYP1A2 GENES IN HUMAN LIVER
    SCHWEIKL, H
    TAYLOR, JA
    KITAREEWAN, S
    LINKO, P
    NAGORNEY, D
    GOLDSTEIN, JA
    PHARMACOGENETICS, 1993, 3 (05): : 239 - 249
  • [9] cDNA cloning and characterization of feline CYP1A1 and CYP1A2
    Tanaka, Nagako
    Miyasho, Taku
    Shinkyo, Raku
    Sakaki, Toshiyuki
    Yokota, Hiroshi
    LIFE SCIENCES, 2006, 79 (26) : 2463 - 2473
  • [10] Rat hepatic CYP1A1 and CYP1A2 induction by menadione
    Sidorova, YA
    Grishanova, AY
    Lyakhovich, VV
    TOXICOLOGY LETTERS, 2005, 155 (02) : 253 - 258